Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

• المؤلفون الرئيسيون: Bartlett J., Ribaudo H., Wallis C., Aga E., Katzenstein D., Stevens W., Norton M., Klingman K., Hosseinipour M., Crump J., Supparatpinyo K., Badal-Faesen S., Kallungal B., Kumarasamy N.
• التنسيق: دورية
• منشور في: 2017
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84863718841&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42812

Objective: To evaluate virologic response rates of lopinavir/ritonavir (LPV/r) monotherapy as second-line antiretroviral treatment (ART) among adults in resource-limited settings (RLSs). Design: An open-label pilot study of LPV/r monotherapy in participants on first-line nonnucleoside reverse transc...